NCT01917656 - Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes | Biotech Hunter

Enrollment

343

Participants

Timeline

Start Date

January 9, 2014

Primary Completion Date

September 1, 2014

Study Completion Date

September 4, 2014

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

liraglutide

1.8 mg administered subcutaneously (s.c., under the skin) once daily

DRUG

metformin

Subjects will continue on their pre-trial metformin tablet treatment, dose unchanged

DRUG

sulphonylurea

Subjects will continue on their pre-trial SU tablet treatment, doses unchanged

Trial Locations (41)

24

Novo Nordisk Investigational Site, Umm Al Quwain City

1501

Novo Nordisk Investigational Site, Benoni

1812

Novo Nordisk Investigational Site, Johannesburg

1827

Novo Nordisk Investigational Site, Johannesburg

Novo Nordisk Investigational Site, Lenasia

3500

Novo Nordisk Investigational Site, Sharjah city

4091

Novo Nordisk Investigational Site, Durban

4092

Novo Nordisk Investigational Site, Durban

4450

Novo Nordisk Investigational Site, Durban

4545

Novo Nordisk Investigational Site, Dubai

4727

Novo Nordisk Investigational Site, Ras al-Khaimah

9115

Novo Nordisk Investigational Site, Dubai

9611

Novo Nordisk Investigational Site, Lebanon - Beirut

16000

Novo Nordisk Investigational Site, Algiers

16150

Novo Nordisk Investigational Site, Kota Bharu, Kelantan

19000

Novo Nordisk Investigational Site, Sétif

21499

Novo Nordisk Investigational Site, Ajman

22000

Novo Nordisk Investigational Site, Sidi Bel Abbes

25000

Novo Nordisk Investigational Site, Constantine

30990

Novo Nordisk Investigational Site, Ipoh, Perak

31000

Novo Nordisk Investigational Site, Oran

31096

Novo Nordisk Investigational Site, Haifa

35152

Novo Nordisk Investigational Site, Haifa

41200

Novo Nordisk Investigational Site, Klang, Selangor

56000

Novo Nordisk Investigational Site, Cheras

62250

Novo Nordisk Investigational Site, Putrajaya

68000

Novo Nordisk Investigational Site, Selangor Darul Ehsan

70400

Novo Nordisk Investigational Site, Seremban, Negeri Sembilan

84101

Novo Nordisk Investigational Site, Beersheba

93106

Novo Nordisk Investigational Site, Jerusalem

380007

Novo Nordisk Investigational Site, Ahmedabad

400008

Novo Nordisk Investigational Site, Mumbai

400010

Novo Nordisk Investigational Site, Mumbai

400058

Novo Nordisk Investigational Site, Mumbai

411001

Novo Nordisk Investigational Site, Pune

500034

Novo Nordisk Investigational Site, Hyderabad

560002

Novo Nordisk Investigational Site, Bangalore

570001

Novo Nordisk Investigational Site, Mysore

570004

Novo Nordisk Investigational Site, Mysore

Unknown

Novo Nordisk Investigational Site, Beirut

0181

Novo Nordisk Investigational Site, Pretoria